These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 19227950

  • 1. [Treatment of Waldenström macroglobulinaemia--the experience of one centre].
    Adam Z, Pour L, Krejcí M, Korístek Z, Navrátil M, Krivanová A, Zahradová L, Hájek R.
    Vnitr Lek; 2009 Jan; 55(1):9-17. PubMed ID: 19227950
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of 72 newly diagnosed Waldenstrom macroglobulinemia cases with oral melphalan, cyclophosphamide, and prednisone: results and cost analysis.
    Annibali O, Petrucci MT, Martini V, Tirindelli MC, Levi A, Fossati C, Del Bianco P, Mandelli F, Foa R, Avvisati G.
    Cancer; 2005 Feb 01; 103(3):582-7. PubMed ID: 15611977
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia.
    Treon SP, Agus TB, Link B, Rodrigues G, Molina A, Lacy MQ, Fisher DC, Emmanouilides C, Richards AI, Clark B, Lucas MS, Schlossman R, Schenkein D, Lin B, Kimby E, Anderson KC, Byrd JC.
    J Immunother; 2001 Feb 01; 24(3):272-9. PubMed ID: 11394506
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Low-dose thalidomide in refractory and relapsing multiple myeloma].
    Radocha J, Maisnar V.
    Vnitr Lek; 2007 Feb 01; 53(2):129-34. PubMed ID: 17419173
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CD20-Directed Antibody-Mediated Immunotherapy Induces Responses and Facilitates Hematologic Recovery in Patients With Waldenstrom's Macroglobulinemia.
    Treon SP, Agus DB, Link B, Rodrigues G, Molina A, Lacy MQ, Fisher DC, Emmanouilides C, Richards AI, Clark B, Lucas MS, Schlossman R, Schenkein D, Lin B, Kimby E, Anderson KC, Byrd JC.
    J Immunother (1991); 2001 May 01; 24(3):272-279. PubMed ID: 11395644
    [Abstract] [Full Text] [Related]

  • 13. Myelodysplastic syndrome with complex karyotypic abnormality in a patient with Waldenström's macroglobulinemia after sequential treatment with chlorambucil and fludarabine.
    Shin SJ, Chun SH, Kim KO, Kim MK, Lee KH, Hyun MS, Cho HS.
    Jpn J Clin Oncol; 2005 Oct 01; 35(10):622-5. PubMed ID: 16172172
    [Abstract] [Full Text] [Related]

  • 14. Waldenstrom's macroglobulinemia: a retrospective analysis of 40 patients from 1972 to 2001.
    Ngan S, Rohatiner AZ, Matthews J, Williams A, Amess JA, Norton A, Lister TA.
    Semin Oncol; 2003 Apr 01; 30(2):236-8. PubMed ID: 12720143
    [Abstract] [Full Text] [Related]

  • 15. Initial immunoglobulin M 'flare' after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: an Eastern Cooperative Oncology Group Study.
    Ghobrial IM, Fonseca R, Greipp PR, Blood E, Rue M, Vesole DH, Gertz MA, Eastern Cooperative Oncology Group.
    Cancer; 2004 Dec 01; 101(11):2593-8. PubMed ID: 15493038
    [Abstract] [Full Text] [Related]

  • 16. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Gertz MA, Anagnostopoulos A, Anderson K, Branagan AR, Coleman M, Frankel SR, Giralt S, Levine T, Munshi N, Pestronk A, Rajkumar V, Treon SP.
    Semin Oncol; 2003 Apr 01; 30(2):121-6. PubMed ID: 12720120
    [Abstract] [Full Text] [Related]

  • 17. Transplantation in Waldenstrom's macroglobulinemia--the French experience.
    Tournilhac O, Leblond V, Tabrizi R, Gressin R, Senecal D, Milpied N, Cazin B, Divine M, Dreyfus B, Cahn JY, Pignon B, Desablens B, Perrier JF, Bay JO, Travade P.
    Semin Oncol; 2003 Apr 01; 30(2):291-6. PubMed ID: 12720155
    [Abstract] [Full Text] [Related]

  • 18. [The treatment of Waldenström macroglobulinemia and the therapy of diseases caused by monoclonal IgM gammaglobulin].
    Adam Z, Scudla V, Krejcí M, Korístek Z.
    Vnitr Lek; 2008 Jan 01; 54(1):68-83. PubMed ID: 18390120
    [Abstract] [Full Text] [Related]

  • 19. Clinico-pathological characteristics of myeloid sarcoma at diagnosis and during follow-up: report of 12 cases from a single institution.
    Breccia M, Mandelli F, Petti MC, D'Andrea M, Pescarmona E, Pileri SA, Carmosino I, Russo E, De Fabritiis P, Alimena G.
    Leuk Res; 2004 Nov 01; 28(11):1165-9. PubMed ID: 15380340
    [Abstract] [Full Text] [Related]

  • 20. Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases.
    Huang YW, Saidi P, Philipp C.
    Haemophilia; 2004 Nov 01; 10(6):713-21. PubMed ID: 15569166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.